NEJM: Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer
The incidence of anal cancer is substantially higher among persons living with the human immunodeficiency virus (HIV) than in the general
The incidence of anal cancer is substantially higher among persons living with the human immunodeficiency virus (HIV) than in the general
Subjects with HIV who had precancerous lesions and got proactive treatment had a 57% lower rate of progressing to cancer.
HPV (human papillomavirus) is associated with 630,000 cancer diagnoses around the world. Almost all cases of cervical and anal cancers are caused
Prompt treatment of precancerous lesions reduced the likelihood of developing anal cancer by 57%.
A protocol in which high-grade squamous intraepithelial lesions (HSIL) of the anal canal were immediately treated was more effective for
Screening for precancerous anal cell changes and treating them early lowers the risk of progression to anal cancer in people living with HIV,
Treating high-grade squamous intraepithelial lesions — primarily with office-based electrocautery — led to an almost 60% reduction in anal cancer
Anal cancer is not exactly rampant in people living with HIV (PLWH). According to University of California San Francisco’s Joel Palefsky, M.D., a
For many years, the lack of randomised data has limited screening programmes for anal cancer, even though rates are significantly higher in people
"In theory, looking for and treating high-grade disease (like we know works in the cervix) is a potential way to prevent anal cancer in high-risk